Platelets Induced Vasodilation, in Vitro and in Vivo Study
NCT00152646 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 36
Last updated 2010-02-04
Summary
The aim of the study is to show the implication of platelets in vasodilation using in vivo and in vitro analysis and to compare the effects of placebo, aspirin and Clopidogrel in this interaction platelets/vessels.
The effects of 7 days of each treatment will be compared in healthy subjects and patients with arteriopathy.
Conditions
- Peripheral Arterial Disease
Interventions
- DRUG
-
placebo, aspirine, clopidogrel
Sponsors & Collaborators
-
University Hospital, Angers
lead OTHER_GOV
Principal Investigators
-
Marc Antoine Custaud, MD PhD · University Hospital, Angers
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2005-03-31
- Completion
- 2008-01-31
Countries
- France
Study Locations
More Related Trials
-
Patients Undergoing Percutaneous Coronary Intervention (PCI) Through Optimal Platelet Inhibition
NCT01582217 ·Status: COMPLETED
-
Investigation of the Athero-Protective Effects of Clopidogrel
NCT01283282 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Clopidogrel Loading and Risk of PCI
NCT00457236 ·Status: UNKNOWN
-
Evaluating Additional Platelet Inhibition in Patients With High Platelet Reactivity Undergoing Percutaneous Coronary Intervention
NCT01339026 ·Status: TERMINATED ·Phase: PHASE4
-
Platelet Inhibition and Transcranial Doppler (TCD)-Detected Microemboli During and After Carotid Artery Stenting (CAS) in Asymptomatic Patients Prior to Cardiac Surgery
NCT01146301 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacodynamic Study of Cilostazol in Healthy Volunteers
NCT02554721 ·Status: COMPLETED ·Phase: PHASE1
-
Impact of Clopidogrel Dose Adjustment According to Platelet Reactivity Monitoring in Patients With High on Treatment Platelet Reactivity Undergoing Percutaneous Coronary Intervention
NCT01505790 ·Status: COMPLETED ·Phase: PHASE3
-
Studying the Efficacy of Aspirin & Clopidogrel in Healthy Subjects With Stable Coronary Artery Disease.
NCT01011257 ·Status: WITHDRAWN ·Phase: PHASE4
-
Influence of Varenicline on the Antiplatelet Action of Clopidogrel
NCT01308671 ·Status: UNKNOWN ·Phase: NA
-
Relationship Between Dosage of Clopidogrel and Platelet Aggregation in Chinese With Different Genotype
NCT01710436 ·Status: UNKNOWN
-
Role of Plavix in Hemorrhagic and Ischemic Complications of Catheterization.
NCT00421252 ·Status: TERMINATED ·Phase: PHASE4
-
Platelet Reactivity in PAD Undergoing Percutaneous Angioplasty
NCT04165629 ·Status: UNKNOWN
-
Evaluation of Platelet Aggregability in Patients With Previous Acute Myocardial Infarction or Concomitant Lower Extremity Peripheral Artery Disease
NCT06454045 ·Status: ACTIVE_NOT_RECRUITING
-
Clopidogrel as Adjunctive Reperfusion Therapy - Thrombolysis in Myocardial Infarction
NCT00714961 ·Status: COMPLETED ·Phase: PHASE3
-
Clopidogrel Response Evaluation and AnTi-Platelet InterVEntion in High Thrombotic Risk PCI Patients
NCT01779401 ·Status: COMPLETED ·Phase: NA
-
Comparative Pharmacokinetics Study of Clopidogrel and Aspirin Fixed-dose Combination Versus Separate Combination-2nd Trial
NCT01496261 ·Status: COMPLETED ·Phase: PHASE1
-
Anti-Inflammatory and Anti-Platelet Effect of Clopidogrel and Aspirin vs Aspirin Alone in Symptomatic Polyvascular Disease and in Patients With Multiple Recurrent Cardiovascular Events
NCT00775762 ·Status: UNKNOWN ·Phase: PHASE3
-
Residual Platelet Reactivity in Patients on Antiplatelet Therapy After Carotid Angioplasty With Stenting
NCT01449617 ·Status: UNKNOWN
-
Clopidogrel Monotherapy in Patients With High Bleeding Risk
NCT05223335 ·Status: COMPLETED ·Phase: PHASE4
-
Genotype-guided Strategy for Antithrombotic Treatment in Peripheral Arterial Disease.
NCT04619927 ·Status: UNKNOWN ·Phase: PHASE4
-
Evaluation of Platelet Function After Statin Loading Dose in Patients Before Percutaneous Coronary Intervention
NCT01526460 ·Status: COMPLETED ·Phase: PHASE2
-
Ticagrelor Versus High-dose Clopidogrel in Patients With High Platelet Reactivity on Clopidogrel After PCI
NCT03078465 ·Status: WITHDRAWN ·Phase: PHASE3
-
Effects of Optimized Antiplatelet Treatment After Percutaneous Coronary Intervention
NCT00404781 ·Status: COMPLETED ·Phase: PHASE4
-
Pilot Study to Examine the Use of Rivaroxaban After Angioplasty for Critical Limb Ischemia
NCT02260622 ·Status: COMPLETED ·Phase: PHASE2
-
The Comparison of Effects Between Increased Dose of Clopidogrel and Addition of Cilostazol
NCT00620646 ·Status: COMPLETED ·Phase: NA